CancerMDCTDOSENCT01436006
Adult and Paediatric Patient Radiation Doses From Multidetector Row Computed Tomography Scans: a National Survey
An observational study of Cancer, run by University of Palermo at 1 site in Italy.
Trial summary
The situation in Italy regarding radiation dose to patients undergoing Multidetector row Computed Tomography (MDCT) scans is unclear despite Italian law require that each centre check the Reference Dose Level (RDL) every two years. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Cancer
- How many people
- 6,700 participants
- Where
- 1 siteItaly
- Study dates
- Feb 2011to Jun 2012
- Phase
- Observational
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Patient that will need a CT scan between March 2011 and February 2012
Who may be able to join
- Patients that will be submitted to "standard" protocols for CT of the: head, chest, abdomen, lumbar spine and cardiac
Who cannot join
- Non standard MDCT examination
Trial locations and contacts
1 site in 1 country.
Italy1 site
Azienda Ospedaliero Universitaria Policlinico
Palermo, Italy/Sicily, 90127
About this study
Official title: Adult and Paediatric Patient Radiation Doses From Multidetector CT Scans: a National Survey
The situation in Italy regarding radiation dose to patients undergoing Multidetector row Computed Tomography (MDCT) scans is unclear despite Italian law require that each centre check the Reference Dose Level (RDL) every two years. RDL in CT were first suggested in a document of 1998 published by the European Commission (EUR16262/1998) based on the results of an older survey in the UK from the late 1980s. Those RDLs, expressed in terms of Computed Tomography Dose Index (CTDI) and Dose Length Product (DLP), are reported in the Italian law (D.Lgs.187/00). However, in Italy there is no governmental authority comparable to the UK's National Radiological Protection Board, deputed to dose evaluation and protection.
An overview of the Italian situation is relevant in order to know the actual dose levels for MDCT administered to patients both adults and paediatrics.
Read the detailed description
CT imaging is rapidly growing and now represents an indispensable medical procedure for many clinical conditions. The widespread availability and expanding use of multidetector CT (MSCT) due to its high performance and very short acquisition times, has resulted in an increase in both frequency of procedures and level of patient exposures from CT scan examinations, but issues related to radiation, including potential risks, have been relatively neglected. Particular attention should be given to CT scans in children, as they represent about 10% of all the X-ray studies performed on them, accounting for about 75% of the total dose administered. CT in children should be performed only when absolutely necessary as their longer life expectation and sensitivity to X-ray radiations may increase the risk of causing radiation-induced neoplasm's in later years.
According to the 2000 report of the United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) the frequency of CT examinations in countries with high healthcare levels has increased by a factor of 8; with the mean effective dose increasing from 1,3 mSv in the 1970s to 8,8 mSv per year per 1000 persons in the early 1990s. In Switzerland, Germany and United Kingdom the increases in the number of reported CT examinations ranged between 39% and 70% over just the period 1998-2002. The 2000 ISTAT report's estimated that 1479 CT apparatus were installed in Italy performing a total of 3.327.750 CT examinations [3]. Considering an increase of 40% every 5 years, comparable to other European countries, 6.000.000 CT examinations can be estimated for 2010.
The primary objective of the study is to obtain a snapshot of Italian CT practice in adults and children that is up-to-date in regards to information concerning multidetector 16- and 64- row CT. A second goal is to update the national reference dose levels.
The study should further establish a sustainable database for the ongoing collation of further data from local surveys of CT. This will facilitate the analysis of trends and periodic review of national reference doses for CT in a way similar to other European countries.
Radiology departments dealing with adult and paediatric CT in Italy will receive an invitation to participate to the survey and a questionnaire regarding some important features of their CT equipment. Four common protocols will be used for dose calculation: CT scan of the head, lumbar spine, chest and abdomen. Cardiac CT data will be collected only for adults, as in children other examinations, such as MR are commonly preferred to CT just for radioprotection reasons.
All radiology departments using a 16 or 64 multidetector CT will be sought for enrolment in the study. Centres that perform at least 2000 MDCT examinations in either adults or paediatrics in one year and do a regular quality control on their CT scanner will be included in the survey list and divided according to their geographical site, namely the four macro-areas of Northern Italy, Centre, Southern Italy and Islands.
Each enrolled centre will receive a standardized form to fill in. The main technical parameters included in the questionnaire will be: CT scanner manufacturer, model and type, characteristics of automatic modulation system (modulation directions and chosen image quality level e.g. Noise Index and effective mAs). Tube voltage (kV), current (mA), tube rotation time(s), slice thickness, total acquisition time (s), pitch, filtration should also be given. For each patient examination Volumetric Computed Tomography Dose Index (CTDIvol) and Dose Length Product (DLP) should be collected from the dose report. For the cardiac protocol, a dedicated questionnaire will be distributed including typical cardiac parameters in addition to those mentioned above. For the protocols performed on adults, data are requested for normal patients (excluding those who were excessively small or large). For children, the age at examinations and weight are included. Paediatric studies will be those of persons less than 16 years old, as established by the Italian regulation.
In order to verify the accuracy of the console displayed values a medical physicist should measure before starting the survey the CTDIvol following the European Guidelines EUR16262/1998. Errors less then 10% between the measured and reported value will be accepted.
Each protocol will be analysed separately and descriptive statistical analysis of the main parameters will be performed. These include sample size, range, median, mean value, third quartile and percentage coefficient of variation.
The survey will be conducted over a period of twelve months. The data will be treated in an anonymous way, with the centres being coded by alphabetical letters. The investigators calculate that a sample size of 2,421 MDCT examinations for each protocol will be sufficient to guarantee a confidence of 90% and an absolute error of 5% of the average dose, with simple random sampling and assuming a conservative hypothesis that the population standard deviation is five times that estimated in a similar German survey [4].
In order to increase the accuracy of the estimation the investigators will adopt a stratified random sampling scheme that consists of stratification into the four geographical Italian macro-areas and the random selection of a number of MDCT examinations proportional to the population living in each macro-area. Stratification facilitates the tasks of data collection and survey, and aides in removing a possible source of bias related to the different frequency of MDCT apparatus, as MDCT services will be clustered into internally homogeneous strata.
- Conditions
- Cancer
- Keywords
- MDCT, radiation, dose
- Medical subject headings
- Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| CT scan | patient with cancer |
What is being measured
The primary outcome is the main question the study is designed to answer.
Value of Mean Volumetric Computed Tomography Dose Index (CTDI Vol) for Head CT Examinations.
Measured: One year
Value of Mean Volumetric Computed Tomography Dose Index (CTDI Vol) for Chest CT Examinations.
Measured: one year
Value of Mean Volumetric Computed Tomography Dose Index (CTDI Vol) for Abdomen CT Examinations.
Measured: one year
Value of Mean Volumetric Computed Tomography Dose Index (CTDI Vol) for Cardiac CT Examinations.
Measured: one year
Value of Mean Volumetric Computed Tomography Dose Index (CTDI Vol) for Chest Abdomen and Pelvis CT Examinations.
Measured: one year
Value of Mean Volumetric Computed Tomography Dose Index (CTDI Vol) for Spine CT Examinations.
Measured: one year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Sep 2011 (estimated)
- Study startFeb 2011
- Primary completionOct 2011
- Study completionJun 2012
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for CancerStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Retrospective
- Enrolment
- 6,700 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Palermo
- Sponsor type
- University, hospital or other
- Collaborators
- Società Italiana di Radiologia Medica
- Responsible party
- Principal investigator, Sergio Salerno, University of Palermo
- Investigators
- Sergio Salerno, Prof., Principal investigator, University of PalermoDaniela Origgi, PhD, Study director, European Institute of Oncology
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01436006
- Sponsor's protocol ID
- MDCTDOSE/SIRM
- Acronym
- MDCTDOSE
- Status last verified
- Sep 2015
- First submitted
- 28 Jul 2011
- Last updated
- 18 Sep 2015
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- Yes
Publications
Frush DP, Applegate K. Computed tomography and radiation: understanding the issues. J Am Coll Radiol. 2004 Feb;1(2):113-9. doi: 10.1016/j.jacr.2003.11.012.
PubMed 17411538Brenner DJ, Hall EJ. Computed tomography--an increasing source of radiation exposure. N Engl J Med. 2007 Nov 29;357(22):2277-84. doi: 10.1056/NEJMra072149. No abstract available.
PubMed 18046031Brenner DJ, Shuryak I, Einstein AJ. Impact of reduced patient life expectancy on potential cancer risks from radiologic imaging. Radiology. 2011 Oct;261(1):193-8. doi: 10.1148/radiol.11102452. Epub 2011 Jul 19.
PubMed 21771956
Study at a glance
From the registry record, last updated by the sponsor on 18 Sep 2015. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Adult and Paediatric Patient Radiation Doses From Multidetector CT Scans: a National Survey
- ClinicalTrials.gov ID
- NCT01436006
- Acronym / sponsor ID
- MDCTDOSE / MDCTDOSE/SIRM
- Conditions
- Cancer
- Keywords
- MDCT, radiation, dose
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 6,700 participants (actual)
- Lead sponsor
- University of PalermoUniversity, hospital or other
- Collaborators
- Società Italiana di Radiologia Medica
- Study start
- Feb 2011
- Primary completion
- Oct 2011 (actual)
- Study completion
- Jun 2012 (actual)
- First posted
- 19 Sep 2011 (estimated)
- Results
- Posted 4 Aug 2015
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The situation in Italy regarding radiation dose to patients undergoing Multidetector row Computed Tomography (MDCT) scans is unclear despite Italian law require that each centre check the Reference Dose Level (RDL) every two years. RDL in CT were first suggested in a document of 1998 published by the European Commission (EUR16262/1998) based on the results of an older survey in the UK from the late 1980s. Those RDLs, expressed in terms of Computed Tomography Dose Index (CTDI) and Dose Length Product (DLP), are reported in the Italian law (D.Lgs.187/00). However, in Italy there is no governmental authority comparable to the UK's National Radiological Protection Board, deputed to dose evaluation and protection.
An overview of the Italian situation is relevant in order to know the actual dose levels for MDCT administered to patients both adults and paediatrics.
Detailed description
CT imaging is rapidly growing and now represents an indispensable medical procedure for many clinical conditions. The widespread availability and expanding use of multidetector CT (MSCT) due to its high performance and very short acquisition times, has resulted in an increase in both frequency of procedures and level of patient exposures from CT scan examinations, but issues related to radiation, including potential risks, have been relatively neglected. Particular attention should be given to CT scans in children, as they represent about 10% of all the X-ray studies performed on them, accounting for about 75% of the total dose administered. CT in children should be performed only when absolutely necessary as their longer life expectation and sensitivity to X-ray radiations may increase the risk of causing radiation-induced neoplasm's in later years.
According to the 2000 report of the United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) the frequency of CT examinations in countries with high healthcare levels has increased by a factor of 8; with the mean effective dose increasing from 1,3 mSv in the 1970s to 8,8 mSv per year per 1000 persons in the early 1990s. In Switzerland, Germany and United Kingdom the increases in the number of reported CT examinations ranged between 39% and 70% over just the period 1998-2002. The 2000 ISTAT report's estimated that 1479 CT apparatus were installed in Italy performing a total of 3.327.750 CT examinations [3]. Considering an increase of 40% every 5 years, comparable to other European countries, 6.000.000 CT examinations can be estimated for 2010.
The primary objective of the study is to obtain a snapshot of Italian CT practice in adults and children that is up-to-date in regards to information concerning multidetector 16- and 64- row CT. A second goal is to update the national reference dose levels.
The study should further establish a sustainable database for the ongoing collation of further data from local surveys of CT. This will facilitate the analysis of trends and periodic review of national reference doses for CT in a way similar to other European countries.
Radiology departments dealing with adult and paediatric CT in Italy will receive an invitation to participate to the survey and a questionnaire regarding some important features of their CT equipment. Four common protocols will be used for dose calculation: CT scan of the head, lumbar spine, chest and abdomen. Cardiac CT data will be collected only for adults, as in children other examinations, such as MR are commonly preferred to CT just for radioprotection reasons.
All radiology departments using a 16 or 64 multidetector CT will be sought for enrolment in the study. Centres that perform at least 2000 MDCT examinations in either adults or paediatrics in one year and do a regular quality control on their CT scanner will be included in the survey list and divided according to their geographical site, namely the four macro-areas of Northern Italy, Centre, Southern Italy and Islands.
Each enrolled centre will receive a standardized form to fill in. The main technical parameters included in the questionnaire will be: CT scanner manufacturer, model and type, characteristics of automatic modulation system (modulation directions and chosen image quality level e.g. Noise Index and effective mAs). Tube voltage (kV), current (mA), tube rotation time(s), slice thickness, total acquisition time (s), pitch, filtration should also be given. For each patient examination Volumetric Computed Tomography Dose Index (CTDIvol) and Dose Length Product (DLP) should be collected from the dose report. For the cardiac protocol, a dedicated questionnaire will be distributed including typical cardiac parameters in addition to those mentioned above. For the protocols performed on adults, data are requested for normal patients (excluding those who were excessively small or large). For children, the age at examinations and weight are included. Paediatric studies will be those of persons less than 16 years old, as established by the Italian regulation.
In order to verify the accuracy of the console displayed values a medical physicist should measure before starting the survey the CTDIvol following the European Guidelines EUR16262/1998. Errors less then 10% between the measured and reported value will be accepted.
Each protocol will be analysed separately and descriptive statistical analysis of the main parameters will be performed. These include sample size, range, median, mean value, third quartile and percentage coefficient of variation.
The survey will be conducted over a period of twelve months. The data will be treated in an anonymous way, with the centres being coded by alphabetical letters. The investigators calculate that a sample size of 2,421 MDCT examinations for each protocol will be sufficient to guarantee a confidence of 90% and an absolute error of 5% of the average dose, with simple random sampling and assuming a conservative hypothesis that the population standard deviation is five times that estimated in a similar German survey [4].
In order to increase the accuracy of the estimation the investigators will adopt a stratified random sampling scheme that consists of stratification into the four geographical Italian macro-areas and the random selection of a number of MDCT examinations proportional to the population living in each macro-area. Stratification facilitates the tasks of data collection and survey, and aides in removing a possible source of bias related to the different frequency of MDCT apparatus, as MDCT services will be clustered into internally homogeneous strata.
Study design
- Observational model
- Case only
- Time perspective
- Retrospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| CT scan | – | –patient with cancer |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Patient that will need a CT scan between March 2011 and February 2012
Key inclusion criteria (1 listed)
- Patients that will be submitted to "standard" protocols for CT of the: head, chest, abdomen, lumbar spine and cardiac
Key exclusion criteria (1 listed)
- Non standard MDCT examination
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Value of Mean Volumetric Computed Tomography Dose Index (CTDI Vol) for Head CT Examinations.
Time frame: One year
Value of Mean Volumetric Computed Tomography Dose Index (CTDI Vol) for Chest CT Examinations.
Time frame: one year
Value of Mean Volumetric Computed Tomography Dose Index (CTDI Vol) for Abdomen CT Examinations.
Time frame: one year
Value of Mean Volumetric Computed Tomography Dose Index (CTDI Vol) for Cardiac CT Examinations.
Time frame: one year
Value of Mean Volumetric Computed Tomography Dose Index (CTDI Vol) for Chest Abdomen and Pelvis CT Examinations.
Time frame: one year
Value of Mean Volumetric Computed Tomography Dose Index (CTDI Vol) for Spine CT Examinations.
Time frame: one year
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Sep 2015.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
- Results publication: PubMed 17411538Frush DP, Applegate K. Computed tomography and radiation: understanding the issues. J Am Coll Radiol. 2004 Feb;1(2):113-9. doi: 10.1016/j.jacr.2003.11.012.
- Results publication: PubMed 18046031Brenner DJ, Hall EJ. Computed tomography--an increasing source of radiation exposure. N Engl J Med. 2007 Nov 29;357(22):2277-84. doi: 10.1056/NEJMra072149. No abstract available.
- Results publication: PubMed 21771956Brenner DJ, Shuryak I, Einstein AJ. Impact of reduced patient life expectancy on potential cancer risks from radiologic imaging. Radiology. 2011 Oct;261(1):193-8. doi: 10.1148/radiol.11102452. Epub 2011 Jul 19.
Related trials for Cancer
Not yet recruitingPhase 1
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Colorectal Neoplasms, Neoplasms
RecruitingPhase 2
Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Active, not recruitingPhase 1/2
Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
Low Grade Glioma, Recurrent Childhood Pilocytic Astrocytoma
Enrolling by invitationPhase 2
A Single-Arm Study of Nimotuzumab Combined With NALIRIFOX as First-Line Treatment for Pancreatic Cancer
Pancreatic Cancer Metastatic
Recruiting
Methylation Profiling in Self-Samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers
Gynaecological Cancers, Ovarian Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Sergio Salerno, Prof. principal investigator
University of Palermo
Daniela Origgi, PhD study director
European Institute of Oncology
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Cancer, run by University of Palermo at 1 site in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 18 Sep 2015. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 4 Aug 2015). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Value of Mean Volumetric Computed Tomography Dose Index (CTDI Vol) for Head CT Examinations. (time frame: One year). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01436006, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Sep 2015.